These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


272 related items for PubMed ID: 9469441

  • 1. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor.
    Soares MB, Titus RG, Shoemaker CB, David JR, Bozza M.
    J Immunol; 1998 Feb 15; 160(4):1811-6. PubMed ID: 9469441
    [Abstract] [Full Text] [Related]

  • 2. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells.
    Eggenberger M, Born W, Zimmermann U, Lerner EA, Fischer JA, Muff R.
    Neuropeptides; 1999 Apr 15; 33(2):107-14. PubMed ID: 10657479
    [Abstract] [Full Text] [Related]

  • 3. The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10.
    Bozza M, Soares MB, Bozza PT, Satoskar AR, Diacovo TG, Brombacher F, Titus RG, Shoemaker CB, David JR.
    Eur J Immunol; 1998 Oct 15; 28(10):3120-7. PubMed ID: 9808180
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Feb 01; 162(3):1707-16. PubMed ID: 9973433
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D.
    J Immunol; 1999 Apr 15; 162(8):4685-96. PubMed ID: 10202009
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Immunol; 1999 Feb 15; 162(4):2358-67. PubMed ID: 9973516
    [Abstract] [Full Text] [Related]

  • 7. Salivary gland homogenates of Lutzomyia longipalpis and its vasodilatory peptide maxadilan cause plasma leakage via PAC1 receptor activation.
    Svensjö E, Saraiva EM, Bozza MT, Oliveira SM, Lerner EA, Scharfstein J.
    J Vasc Res; 2009 Feb 15; 46(5):435-46. PubMed ID: 19176972
    [Abstract] [Full Text] [Related]

  • 8. Maxadilan is a specific agonist and its deleted peptide (M65) is a specific antagonist for PACAP type 1 receptor.
    Uchida D, Tatsuno I, Tanaka T, Hirai A, Saito Y, Moro O, Tajima M.
    Ann N Y Acad Sci; 1998 Dec 11; 865():253-8. PubMed ID: 9928019
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar 11; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 12. Maxadilan, the vasodilator/immunomodulator from Lutzomyia longipalpis sand fly saliva, stimulates haematopoiesis in mice.
    Guilpin VO, Swardson-Olver C, Nosbisch L, Titus RG.
    Parasite Immunol; 2002 Aug 11; 24(8):437-46. PubMed ID: 12406198
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug 11; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 14. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.
    J Cell Physiol; 2009 Oct 11; 221(1):75-83. PubMed ID: 19496170
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Maxadilan, the vasodilator from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist.
    Moro O, Lerner EA.
    J Biol Chem; 1997 Jan 10; 272(2):966-70. PubMed ID: 8995389
    [Abstract] [Full Text] [Related]

  • 18. Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-{kappa}B in chronic pancreatitis.
    Michalski CW, Selvaggi F, Bartel M, Mitkus T, Gorbachevski A, Giese T, Sebastiano PD, Giese NA, Friess H.
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan 10; 294(1):G50-7. PubMed ID: 17962362
    [Abstract] [Full Text] [Related]

  • 19. Maxadilan activates PAC1 receptors expressed in Xenopus laevis xelanophores.
    Pereira P, Reddy VB, Kounga K, Bello Y, Lerner E.
    Pigment Cell Res; 2002 Dec 10; 15(6):461-6. PubMed ID: 12453189
    [Abstract] [Full Text] [Related]

  • 20. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells.
    Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T.
    J Endocrinol; 2007 Nov 10; 195(2):199-211. PubMed ID: 17951532
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.